ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

NCT02933801 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
92
Enrollment
OTHER
Sponsor class

Stopped Decision Board no further financial support after 3 years of follow-up as remaining patients in follow-up phase would not relevantly change the endpoints.

Conditions

Interventions

Sponsor

Swiss Cancer Institute